Warfarin doses in the initiation phase among patients with heart valve replacement and atrial fibrillation in Hospital Pulau Pinang

The use of warfarin is essential in patients having atrial fibrillation (AF), aortic valve replacement (AVR) and mitral valve replacement (MVR). However, the use of warfarin may bring major adverse effects such as bleeding and it has dose related side effects. Due to higher incidence of bleeding...

Full description

Saved in:
Bibliographic Details
Main Author: Jia, Teoh Chee
Format: Thesis
Language:English
Published: 2011
Subjects:
Online Access:http://eprints.usm.my/57489/1/TEOH%20CHEE%20JIA%20-%20e.pdf
http://eprints.usm.my/57489/
Tags: Add Tag
No Tags, Be the first to tag this record!
id my.usm.eprints.57489
record_format eprints
spelling my.usm.eprints.57489 http://eprints.usm.my/57489/ Warfarin doses in the initiation phase among patients with heart valve replacement and atrial fibrillation in Hospital Pulau Pinang Jia, Teoh Chee R Medicine (General) RM300-666 Drugs and their actions The use of warfarin is essential in patients having atrial fibrillation (AF), aortic valve replacement (AVR) and mitral valve replacement (MVR). However, the use of warfarin may bring major adverse effects such as bleeding and it has dose related side effects. Due to higher incidence of bleeding in initial phase of warfarin therapy and reported fluctuation of dose in initial phase of warfarin therapy after heart valve surgery, this study was conducted to evaluate the changes in warfarin doses among patients after heart valve surgery and atrial fibrillation. All patients having atrial fibrillation, aortic valve replacement and mitral valve replacement who were initiated warfarin therapy in year 2008 till 2010 in Hospital Pulau Pinang was selected as samples. A total of 137 patients were included for this study. Data collected included patient’s age. race, gender, warfarin initiation date, warfarin indication, warfarin dose and INR value for 1st till 12th weeks of warfarin initiation. Statistical analysis was performed using repeated measures ANOVA and repeated measures ANCOVA. Heart valve replacement patients (AVR or MVR) showed increasing trend in warfarin doses during the initial phase of warfarin therapy. This trend was not observed in Al-' patients. The dose of warfarin warfarin initiation for AVR and MVR group (p-value <0.001) but there was no significant difference in AF group. The dose of warfarin was significantly different among AVR and AF patients for first 5 weeks of warfarin initiation. Indications (p-value= 0.036) and race (p-value=0.016) were found to be significantly affecting warfarin doses in the initial phase of warfarin therapy but not gender (p-value =0.122) and age (p-value =0.280). Overall, the mean dose of warfarin required was lower compared to western countries. Monitoring should be frequent for patients with heart valve replacement during the initial 3 months period of warfarin therapy. 2011 Thesis NonPeerReviewed application/pdf en http://eprints.usm.my/57489/1/TEOH%20CHEE%20JIA%20-%20e.pdf Jia, Teoh Chee (2011) Warfarin doses in the initiation phase among patients with heart valve replacement and atrial fibrillation in Hospital Pulau Pinang. Masters thesis, Universiti Sains Malaysia.
institution Universiti Sains Malaysia
building Hamzah Sendut Library
collection Institutional Repository
continent Asia
country Malaysia
content_provider Universiti Sains Malaysia
content_source USM Institutional Repository
url_provider http://eprints.usm.my/
language English
topic R Medicine (General)
RM300-666 Drugs and their actions
spellingShingle R Medicine (General)
RM300-666 Drugs and their actions
Jia, Teoh Chee
Warfarin doses in the initiation phase among patients with heart valve replacement and atrial fibrillation in Hospital Pulau Pinang
description The use of warfarin is essential in patients having atrial fibrillation (AF), aortic valve replacement (AVR) and mitral valve replacement (MVR). However, the use of warfarin may bring major adverse effects such as bleeding and it has dose related side effects. Due to higher incidence of bleeding in initial phase of warfarin therapy and reported fluctuation of dose in initial phase of warfarin therapy after heart valve surgery, this study was conducted to evaluate the changes in warfarin doses among patients after heart valve surgery and atrial fibrillation. All patients having atrial fibrillation, aortic valve replacement and mitral valve replacement who were initiated warfarin therapy in year 2008 till 2010 in Hospital Pulau Pinang was selected as samples. A total of 137 patients were included for this study. Data collected included patient’s age. race, gender, warfarin initiation date, warfarin indication, warfarin dose and INR value for 1st till 12th weeks of warfarin initiation. Statistical analysis was performed using repeated measures ANOVA and repeated measures ANCOVA. Heart valve replacement patients (AVR or MVR) showed increasing trend in warfarin doses during the initial phase of warfarin therapy. This trend was not observed in Al-' patients. The dose of warfarin warfarin initiation for AVR and MVR group (p-value <0.001) but there was no significant difference in AF group. The dose of warfarin was significantly different among AVR and AF patients for first 5 weeks of warfarin initiation. Indications (p-value= 0.036) and race (p-value=0.016) were found to be significantly affecting warfarin doses in the initial phase of warfarin therapy but not gender (p-value =0.122) and age (p-value =0.280). Overall, the mean dose of warfarin required was lower compared to western countries. Monitoring should be frequent for patients with heart valve replacement during the initial 3 months period of warfarin therapy.
format Thesis
author Jia, Teoh Chee
author_facet Jia, Teoh Chee
author_sort Jia, Teoh Chee
title Warfarin doses in the initiation phase among patients with heart valve replacement and atrial fibrillation in Hospital Pulau Pinang
title_short Warfarin doses in the initiation phase among patients with heart valve replacement and atrial fibrillation in Hospital Pulau Pinang
title_full Warfarin doses in the initiation phase among patients with heart valve replacement and atrial fibrillation in Hospital Pulau Pinang
title_fullStr Warfarin doses in the initiation phase among patients with heart valve replacement and atrial fibrillation in Hospital Pulau Pinang
title_full_unstemmed Warfarin doses in the initiation phase among patients with heart valve replacement and atrial fibrillation in Hospital Pulau Pinang
title_sort warfarin doses in the initiation phase among patients with heart valve replacement and atrial fibrillation in hospital pulau pinang
publishDate 2011
url http://eprints.usm.my/57489/1/TEOH%20CHEE%20JIA%20-%20e.pdf
http://eprints.usm.my/57489/
_version_ 1761617406871994368
score 13.211869